LICENSING
BUILD A2P2 INTO YOUR ORGANISATION
A2P2 is licensed as an enterprise framework and protected platform. The objective is to establish a repeatable internal capability across R&D, materials science, quality and regulatory functions—not to sell an isolated calculation.
WHAT AN IMPLEMENTATION INCLUDES
• Annual rights to operate the patented A2P2 methodology within the agreed organisational scope.
• Access to the protected A2P2 platform and applicable computational workflows.
• A foundational programme using the licensee's lead device, material or interface.
• Method transfer, laboratory implementation and team training.
• Study-design, prediction and regulatory-output workflows.
• Defined scientific governance, review and support.
• A governed materials library that grows with each completed programme.
THE ADOPTION PATHWAY
1 · QUALIFICATION
Confirm the product portfolio, scientific need, internal capability and intended regulatory use.
2 · FOUNDATIONAL IMPLEMENTATION
Apply A2P2 to one lead system, establish the governing mechanism and demonstrate the complete evidence pathway.
3 · METHOD TRANSFER
Train the relevant teams, establish laboratory procedures and embed governance.
4 · PORTFOLIO SCALE
Extend the framework across additional devices, materials and lifetime decisions.
WHO IT IS FOR
Medical-device manufacturers, biopharmaceutical and single-use-system organisations, materials suppliers and other regulated product companies with recurring lifetime, stability or shelf-life decisions.
TWO LICENSING PATHWAYS
ENTERPRISE LICENCE
For organisations applying A2P2 internally across their own products, portfolios and regulatory submissions.
AUTHORISED SERVICE-PROVIDER LICENCE
For qualified laboratories and technical-service organisations using A2P2 within governed programmes delivered to third-party customers. This pathway includes defined implementation, training, quality governance and customer-use rights.
External customer services, sublicensing and resale of A2P2-generated work are not included within an enterprise licence and require a separate commercial agreement.
COMMERCIAL STRUCTURE
Licensing is scoped directly against organisational use, deployment breadth and implementation requirements. Commercial terms are discussed with qualified organisations following a scientific and strategic assessment.
Scope reflects internal or customer-facing use, business units, sites, authorised users and implementation requirements.
START A LICENSING DISCUSSION